Pembrolizumab in Muscle-invasive Bladder Cancer

NCT05406713 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Muscle Invasive Bladder Carcinoma
Localized Cancer
Urothelial Carcinoma

Interventions

DRUG: Pembrolizumab

Sponsor

Matthew Galsky

Collaborators

[object Object]